Buprenorphine,Ketamine,Dexmedetomidine
21 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
21
Total Reports
3
Deaths Reported
1430.0%
Death Rate
Active Ingredients
Buprenorphine,Ketamine,Dexmedetomidine
Administration Routes
UnknownParenteralIntramuscular
Species Affected
Cat 21
Most Affected Breeds
Domestic Shorthair 12
Siamese 3
Domestic Longhair 3
Bengal 2
Domestic Mediumhair 1
Most Reported Reactions
Dilated pupils 6
Behavioural disorder NOS 5
Lethargy (see also Central nervous system depression in Neurological) 3
Panting 3
Elevated temperature 3
Not sleeping 3
Lack of efficacy - NOS 3
Ataxia 3
Heart murmur 3
Agitation 2
Quiet 2
Rolling 2
Outcome Breakdown
Recovered/Normal
8 (38.1%)
Ongoing
6 (28.6%)
Outcome Unknown
4 (19.0%)
Died
3 (14.3%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.